2-236214604-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_212556.4(ASB18):c.859G>A(p.Asp287Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000929 in 1,227,422 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_212556.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ASB18 | NM_212556.4 | c.859G>A | p.Asp287Asn | missense_variant | 4/6 | ENST00000409749.8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ASB18 | ENST00000409749.8 | c.859G>A | p.Asp287Asn | missense_variant | 4/6 | 1 | NM_212556.4 | P1 | |
GBX2-AS1 | ENST00000415226.1 | n.224-44903C>T | intron_variant, non_coding_transcript_variant | 4 |
Frequencies
GnomAD3 genomes AF: 0.000114 AC: 17AN: 149684Hom.: 0 Cov.: 32
GnomAD4 exome AF: 0.0000900 AC: 97AN: 1077632Hom.: 0 Cov.: 30 AF XY: 0.0000896 AC XY: 46AN XY: 513262
GnomAD4 genome AF: 0.000113 AC: 17AN: 149790Hom.: 0 Cov.: 32 AF XY: 0.000191 AC XY: 14AN XY: 73118
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 04, 2023 | The c.859G>A (p.D287N) alteration is located in exon 4 (coding exon 4) of the ASB18 gene. This alteration results from a G to A substitution at nucleotide position 859, causing the aspartic acid (D) at amino acid position 287 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at